Which of the following physiologic changes decreases pulmonary vascular resistance (PVR)?
Q2
A 57-year-old man presents to the clinic for a chronic cough over the past 4 months. The patient reports a productive yellow/green cough that is worse at night. He denies any significant precipitating event prior to his symptoms. He denies fever, chest pain, palpitations, weight changes, or abdominal pain, but endorses some difficulty breathing that waxes and wanes. He denies alcohol usage but endorses a 35 pack-year smoking history. A physical examination demonstrates mild wheezes, bibasilar crackles, and mild clubbing of his fingertips. A pulmonary function test is subsequently ordered, and partial results are shown below:
Tidal volume: 500 mL
Residual volume: 1700 mL
Expiratory reserve volume: 1500 mL
Inspiratory reserve volume: 3000 mL
What is the functional residual capacity of this patient?
Q3
A 65-year-old woman presents to her physician with chronic breathlessness. Her condition has been progressively worsening over the last 20 years despite treatment with inhaled salbutamol, inhaled corticosteroids, and multiple courses of antibiotics. She has a 30-pack-year smoking history but quit 20 years ago. Her pulse is 104/min and respirations are 28/min. Physical examination shows generalized wasting. Chest auscultation reveals expiratory wheezes bilaterally and distant heart sounds. Pulmonary function testing shows a non-reversible obstructive pattern. Her carbon monoxide diffusion capacity of the lungs (DLCO) is markedly reduced. Which of the following explains the underlying mechanism of her condition?
Q4
A 30-year-old patient presents to clinic for pulmonary function testing. With body plethysmography, the patient's functional residual capacity is 3 L, tidal volume is 650 mL, expiratory reserve volume is 1.5 L, total lung capacity is 8 L, and dead space is 150 mL. Respiratory rate is 15 breaths per minute. What is the alveolar ventilation?
Q5
A 35-year-old woman volunteers for a study on respiratory physiology. Pressure probes A and B are placed as follows:
Probe A: between the parietal and visceral pleura
Probe B: within the cavity of an alveolus
The probes provide a pressure reading relative to atmospheric pressure. To obtain a baseline reading, she is asked to sit comfortably and breathe normally. Which of the following sets of values will most likely be seen at the end of inspiration?
Q6
In which of the following pathological states would the oxygen content of the trachea resemble the oxygen content in the affected alveoli?
Q7
A 21-year-old lacrosse player comes to the doctor for an annual health assessment. She does not smoke or drink alcohol. She is 160 cm (5 ft 3 in) tall and weighs 57 kg (125 lb); BMI is 22 kg/m2. Pulmonary function tests show an FEV1 of 90% and an FVC of 3600 mL. Whole body plethysmography is performed to measure airway resistance. Which of the following structures of the respiratory tree is likely to have the highest contribution to total airway resistance?
Q8
A 30-year-old woman presents to the emergency department with breathlessness for the last hour. She is unable to provide any history due to her dyspnea. Her vitals include: respiratory rate 20/min, pulse 100/min, and blood pressure 144/84 mm Hg. On physical examination, she is visibly obese, and her breathing is labored. There are decreased breath sounds and hyperresonance to percussion across all lung fields bilaterally. An arterial blood gas is drawn, and the patient is placed on inhaled oxygen. Laboratory findings reveal:
pH 7.34
pO2 63 mm Hg
pCO2 50 mm Hg
HCO3 22 mEq/L
Her alveolar partial pressure of oxygen is 70 mm Hg. Which of the following is the most likely etiology of this patient’s symptoms?
Q9
A 68-year-old man with both severe COPD (emphysema) and newly diagnosed idiopathic pulmonary fibrosis presents with worsening dyspnea. His pressure-volume curve shows a complex pattern with features of both diseases. Static compliance measured at mid-lung volumes is 120 mL/cm H2O. His pulmonologist must decide on optimal management. Synthesizing the pathophysiology of both conditions, what represents the most significant clinical challenge in managing his combined disease?
Q10
A 42-year-old woman with systemic sclerosis develops both pulmonary fibrosis and chest wall restriction from skin thickening. Her measured total respiratory system compliance is 30 mL/cm H2O. Testing with complete paralysis and positive pressure ventilation shows isolated lung compliance of 50 mL/cm H2O. She is being considered for immunosuppressive therapy versus supportive care. Evaluate which intervention would provide the greatest improvement in her respiratory mechanics.
Static vs dynamic compliance US Medical PG Practice Questions and MCQs
Question 1: Which of the following physiologic changes decreases pulmonary vascular resistance (PVR)?
A. Inhaling the inspiratory reserve volume (IRV)
B. Exhaling the entire vital capacity (VC)
C. Exhaling the expiratory reserve volume (ERV)
D. Breath holding maneuver at functional residual capacity (FRC)
E. Inhaling the entire vital capacity (VC) (Correct Answer)
Explanation: ***Inhaling the entire vital capacity (VC)***
- As lung volume increases from FRC to TLC (which includes inhaling the entire VC), alveolar vessels are **stretched open**, and extra-alveolar vessels are **pulled open** by the increased radial traction, leading to a decrease in PVR.
- This **maximizes the cross-sectional area** of the pulmonary vascular bed, lowering resistance.
*Inhaling the inspiratory reserve volume (IRV)*
- While inhaling IRV increases lung volume, it's not the maximal inspiration of the entire VC where **PVR is typically at its lowest**.
- PVR continues to decrease as lung volume approaches total lung capacity (TLC).
*Exhaling the entire vital capacity (VC)*
- Exhaling the entire vital capacity leads to very low lung volumes, where PVR significantly **increases**.
- At low lung volumes, **alveolar vessels become compressed** and extra-alveolar vessels **narrow**, increasing resistance.
*Exhaling the expiratory reserve volume (ERV)*
- Exhaling the ERV results in a lung volume below FRC, which causes a **marked increase in PVR**.
- This is due to the **compression of alveolar vessels** and decreased radial traction on extra-alveolar vessels.
*Breath holding maneuver at functional residual capacity (FRC)*
- At FRC, the PVR is at an **intermediate level**, not its lowest.
- This is the point where the opposing forces affecting alveolar and extra-alveolar vessels are somewhat balanced, but not optimized for minimal resistance.
Question 2: A 57-year-old man presents to the clinic for a chronic cough over the past 4 months. The patient reports a productive yellow/green cough that is worse at night. He denies any significant precipitating event prior to his symptoms. He denies fever, chest pain, palpitations, weight changes, or abdominal pain, but endorses some difficulty breathing that waxes and wanes. He denies alcohol usage but endorses a 35 pack-year smoking history. A physical examination demonstrates mild wheezes, bibasilar crackles, and mild clubbing of his fingertips. A pulmonary function test is subsequently ordered, and partial results are shown below:
Tidal volume: 500 mL
Residual volume: 1700 mL
Expiratory reserve volume: 1500 mL
Inspiratory reserve volume: 3000 mL
What is the functional residual capacity of this patient?
A. 4500 mL
B. 2000 mL
C. 2200 mL
D. 3200 mL (Correct Answer)
E. 3500 mL
Explanation: ***3200 mL***
- The **functional residual capacity (FRC)** is the volume of air remaining in the lungs after a normal expiration.
- It is calculated as the sum of the **expiratory reserve volume (ERV)** and the **residual volume (RV)**. In this case, 1500 mL (ERV) + 1700 mL (RV) = 3200 mL.
*4500 mL*
- This value represents the sum of the **inspiratory reserve volume (3000 mL)** and the **residual volume (1700 mL)**, which does not correspond to a standard lung volume or capacity.
- It does not logically relate to the definition of functional residual capacity.
*2000 mL*
- This value represents the sum of the **tidal volume (500 mL)** and the **expiratory reserve volume (1500 mL)**, which is incorrect for FRC.
- This would represent the inspiratory capacity minus the inspiratory reserve volume, which is not a standard measurement used in pulmonary function testing.
*2200 mL*
- This value could be obtained by incorrectly adding the **tidal volume (500 mL)** and the **residual volume (1700 mL)**, which is not the correct formula for FRC.
- This calculation represents a miscombination of lung volumes that does not correspond to any standard pulmonary capacity measurement.
*3500 mL*
- This value is the sum of the **tidal volume (500 mL)**, the **expiratory reserve volume (1500 mL)**, and the **residual volume (1700 mL)**.
- This would represent the FRC plus the tidal volume, which is not a standard measurement and does not represent the functional residual capacity.
Question 3: A 65-year-old woman presents to her physician with chronic breathlessness. Her condition has been progressively worsening over the last 20 years despite treatment with inhaled salbutamol, inhaled corticosteroids, and multiple courses of antibiotics. She has a 30-pack-year smoking history but quit 20 years ago. Her pulse is 104/min and respirations are 28/min. Physical examination shows generalized wasting. Chest auscultation reveals expiratory wheezes bilaterally and distant heart sounds. Pulmonary function testing shows a non-reversible obstructive pattern. Her carbon monoxide diffusion capacity of the lungs (DLCO) is markedly reduced. Which of the following explains the underlying mechanism of her condition?
A. Decreased partial pressure of alveolar oxygen
B. Contraction of pulmonary smooth muscles
C. Inflammation of the pulmonary bronchi
D. Diminished surface area for gas exchange (Correct Answer)
E. Accumulation of fluid in the alveolar space
Explanation: ***Diminished surface area for gas exchange***
- The patient's history of **30-pack-year smoking** and **non-reversible obstructive pattern** with **markedly reduced DLCO** strongly indicates **emphysema**, a form of COPD.
- **Emphysema** is characterized by the destruction of alveolar walls, leading to enlarged air spaces and a significant **reduction in the surface area available for gas exchange.**
*Decreased partial pressure of alveolar oxygen*
- While a **decreased partial pressure of alveolar oxygen (PAO2)** can occur in severe lung disease due to **ventilation-perfusion mismatch** and hypoventilation, it is not the primary *underlying mechanism* of destruction seen in this patient's presentation.
- The reduced DLCO points directly to an issue with **gas transfer capacity**, which is mainly driven by surface area and membrane thickness, not solely PAO2.
*Contraction of pulmonary smooth muscles*
- **Bronchoconstriction**, or the contraction of pulmonary smooth muscles, is a hallmark of **asthma** and can contribute to the obstructive component in COPD.
- However, the patient's condition is described as **non-reversible** despite bronchodilator treatment, and the severe reduction in **DLCO** suggests a more structural issue than just smooth muscle contraction.
*Inflammation of the pulmonary bronchi*
- **Inflammation of the pulmonary bronchi** is characteristic of **chronic bronchitis**, another component of COPD, which contributes to airway obstruction and mucus production.
- While present, the **markedly reduced DLCO** points more strongly to the **alveolar destruction** of emphysema rather than predominantly bronchial inflammation.
*Accumulation of fluid in the alveolar space*
- **Accumulation of fluid in the alveolar space** occurs in conditions like **pulmonary edema** or **acute respiratory distress syndrome (ARDS)**.
- This would typically present with crackles on auscultation and acute respiratory distress, rather than the chronic, progressive course and wheezing described, and would likely cause a different pattern of DLCO reduction.
Question 4: A 30-year-old patient presents to clinic for pulmonary function testing. With body plethysmography, the patient's functional residual capacity is 3 L, tidal volume is 650 mL, expiratory reserve volume is 1.5 L, total lung capacity is 8 L, and dead space is 150 mL. Respiratory rate is 15 breaths per minute. What is the alveolar ventilation?
A. 7.5 L/min (Correct Answer)
B. 7 L/min
C. 8.5 L/min
D. 8 L/min
E. 6.5 L/min
Explanation: ***7.5 L/min***
- Alveolar ventilation (VA) is calculated as (**tidal volume** - **dead space**) x **respiratory rate**.
- In this case, (650 mL - 150 mL) x 15 breaths/min = 500 mL x 15 = 7500 mL/min, which is 7.5 L/min.
*7 L/min*
- This answer would be obtained if the **dead space** was incorrectly subtracted from the **tidal volume** as 200 mL instead of 150 mL, or if there was a calculation error.
- The correct calculation requires accurate use of the provided tidal volume and dead space.
*8.5 L/min*
- This value is not consistent with the correct formula for alveolar ventilation using the given parameters.
- It does not arise from a common miscalculation of **tidal volume**, **dead space**, or **respiratory rate**.
*8 L/min*
- This result might occur from an incorrect addition or subtraction of volumes, or misapplication of the formula for total minute ventilation instead of alveolar ventilation.
- The formula for **total minute ventilation** is **tidal volume** x **respiratory rate**, which would be 0.65 L x 15 = 9.75 L/min, further demonstrating this option is incorrect for alveolar ventilation.
*6.5 L/min*
- This result would be obtained if the **dead space** was incorrectly assumed to be a larger value or if the calculation for subtraction from **tidal volume** was flawed.
- The correct alveolar ventilation calculation precisely accounts for the wasted ventilation in the dead space.
Question 5: A 35-year-old woman volunteers for a study on respiratory physiology. Pressure probes A and B are placed as follows:
Probe A: between the parietal and visceral pleura
Probe B: within the cavity of an alveolus
The probes provide a pressure reading relative to atmospheric pressure. To obtain a baseline reading, she is asked to sit comfortably and breathe normally. Which of the following sets of values will most likely be seen at the end of inspiration?
A. Probe A: -6 mm Hg; Probe B: 0 mm Hg (Correct Answer)
B. Probe A: 0 mm Hg; Probe B: -1 mm Hg
C. Probe A: -4 mm Hg; Probe B: 0 mm Hg
D. Probe A: -4 mm Hg; Probe B: -1 mm Hg
E. Probe A: -6 mm Hg; Probe B: -1 mm Hg
Explanation: ***Probe A: -6 mm Hg; Probe B: 0 mm Hg***
- At the **end of inspiration**, the **intrapleural pressure (Probe A)** is at its most negative, typically around -6 to -8 cm H2O (equivalent to -4 to -6 mmHg), reflecting the maximum expansion of the thoracic cavity.
- At the **end of inspiration**, just before exhalation begins, there is **no airflow**, so the **intrapulmonary pressure (Probe B)** equalizes with atmospheric pressure, resulting in a 0 mm Hg reading.
*Probe A: 0 mm Hg; Probe B: -1 mm Hg*
- An **intrapleural pressure of 0 mm Hg** would indicate a **pneumothorax** since it should always be negative to prevent lung collapse.
- An **intrapulmonary pressure of -1 mm Hg** would indicate that **inspiration is still ongoing**, as air would be flowing into the lungs.
*Probe A: -4 mm Hg; Probe B: 0 mm Hg*
- While an **intrapulmonary pressure of 0 mm Hg** is correct at the end of inspiration, an **intrapleural pressure of -4 mm Hg** is typical for the **end of expiration (Functional Residual Capacity)** during quiet breathing, not the end of inspiration.
- The **intrapleural pressure becomes more negative** during inspiration due to increased thoracic volume, so -4 mm Hg would be insufficient.
*Probe A: -4 mm Hg; Probe B: -1 mm Hg*
- An **intrapleural pressure of -4 mm Hg** is the normal pressure at the **end of expiration**, not the end of inspiration, where it becomes more negative.
- An **intrapulmonary pressure of -1 mm Hg** indicates that **inspiration is still in progress**, not at its end, as air would still be flowing into the lungs.
*Probe A: -6 mm Hg; Probe B: -1 mm Hg*
- While an **intrapleural pressure of -6 mm Hg** is consistent with the end of inspiration, an **intrapulmonary pressure of -1 mm Hg** means that **airflow is still occurring into the lungs**.
- At the **very end of inspiration**, just before the start of exhalation, airflow momentarily ceases, and intrapulmonary pressure becomes zero relative to the atmosphere.
Question 6: In which of the following pathological states would the oxygen content of the trachea resemble the oxygen content in the affected alveoli?
A. Emphysema
B. Exercise
C. Pulmonary embolism (Correct Answer)
D. Pulmonary fibrosis
E. Foreign body obstruction distal to the trachea
Explanation: ***Pulmonary embolism***
- A pulmonary embolism blocks **blood flow** to a portion of the lung, creating **dead space ventilation** (high V/Q ratio).
- In the affected alveoli, **no blood perfusion** means no oxygen extraction occurs, so the alveolar oxygen content remains **high and similar to tracheal/inspired air**.
- This is the classic physiological state where ventilation continues but perfusion is absent, preventing gas exchange.
*Foreign body obstruction distal to the trachea*
- A complete obstruction **prevents fresh air** from reaching the affected alveoli.
- The trapped gas undergoes **resorption atelectasis**: oxygen is absorbed into capillary blood, CO2 diffuses in, and alveolar gas equilibrates with **venous blood** composition.
- Alveolar oxygen content becomes **very low**, not similar to tracheal air.
*Emphysema*
- Emphysema involves destruction of **alveolar walls** and enlargement of airspaces with impaired gas exchange.
- While V/Q mismatch occurs, oxygen is still extracted by perfusing blood.
- Alveolar oxygen content is **lower than tracheal air** due to ongoing (though inefficient) gas exchange.
*Exercise*
- During exercise, **oxygen consumption increases** dramatically with enhanced cardiac output and oxygen extraction.
- Alveolar oxygen content is **significantly lower** than tracheal air due to increased oxygen uptake by blood.
*Pulmonary fibrosis*
- Pulmonary fibrosis causes **thickening of the alveolar-capillary membrane**, impairing oxygen diffusion.
- Despite diffusion limitation, blood still perfuses the alveoli and extracts oxygen.
- Alveolar oxygen content is **lower than tracheal air**, though the A-a gradient is increased.
Question 7: A 21-year-old lacrosse player comes to the doctor for an annual health assessment. She does not smoke or drink alcohol. She is 160 cm (5 ft 3 in) tall and weighs 57 kg (125 lb); BMI is 22 kg/m2. Pulmonary function tests show an FEV1 of 90% and an FVC of 3600 mL. Whole body plethysmography is performed to measure airway resistance. Which of the following structures of the respiratory tree is likely to have the highest contribution to total airway resistance?
A. Conducting bronchioles
B. Terminal bronchioles
C. Segmental bronchi (Correct Answer)
D. Respiratory bronchioles
E. Mainstem bronchi
Explanation: ***Segmental bronchi***
- In healthy individuals, **medium-sized bronchi** (including segmental and subsegmental bronchi, approximately generations 4-8) contribute approximately **80% of total airway resistance**.
- While **Poiseuille's Law** states resistance is inversely proportional to radius to the fourth power (R ∝ 1/r⁴), the key factor is the **total cross-sectional area** and **degree of branching**.
- Medium-sized bronchi have moderate individual resistance and **limited parallel branching**, making them the dominant site of resistance.
- This is why diseases affecting medium-sized airways (e.g., asthma, bronchitis) cause significant increases in airway resistance.
*Terminal bronchioles*
- Although individual terminal bronchioles have small radii and high individual resistance, there are **millions of them arranged in parallel**.
- With parallel resistances, total resistance decreases: 1/R_total = 1/R₁ + 1/R₂ + 1/R₃...
- The **massive number** of small airways means their collective resistance is actually quite **low** (~10-20% of total).
- This is why small airways disease is called the "**silent zone**" - significant pathology can occur before detection.
*Conducting bronchioles*
- These airways also benefit from extensive **parallel branching**, reducing their contribution to total resistance.
- They contribute less than medium-sized bronchi due to their large cumulative cross-sectional area.
*Respiratory bronchioles*
- Part of the **respiratory zone** with the largest total cross-sectional area in the lungs.
- Minimal contribution to airway resistance due to enormous parallel arrangement.
- Primary function is **gas exchange**, not air conduction.
*Mainstem bronchi*
- These large airways have **low individual resistance** due to large diameter.
- Together with the trachea, they contribute approximately **20% of total airway resistance**.
- Not the primary site despite being early in the airway tree.
Question 8: A 30-year-old woman presents to the emergency department with breathlessness for the last hour. She is unable to provide any history due to her dyspnea. Her vitals include: respiratory rate 20/min, pulse 100/min, and blood pressure 144/84 mm Hg. On physical examination, she is visibly obese, and her breathing is labored. There are decreased breath sounds and hyperresonance to percussion across all lung fields bilaterally. An arterial blood gas is drawn, and the patient is placed on inhaled oxygen. Laboratory findings reveal:
pH 7.34
pO2 63 mm Hg
pCO2 50 mm Hg
HCO3 22 mEq/L
Her alveolar partial pressure of oxygen is 70 mm Hg. Which of the following is the most likely etiology of this patient’s symptoms?
A. Right to left shunt
B. Alveolar hypoventilation (Correct Answer)
C. Ventricular septal defect
D. Impaired gas diffusion
E. Ventilation/perfusion mismatch
Explanation: ***Alveolar hypoventilation***
- The patient exhibits features of **obesity** and **labored breathing** with decreased breath sounds and hyperresonance, along with arterial blood gas results showing **respiratory acidosis** (pH 7.34, pCO2 50 mmHg) and **hypoxia** (pO2 63 mmHg).
- The calculated A-a gradient (Alveolar O2 - arterial O2) is low (70 mmHg - 63 mmHg = 7 mmHg), indicating that the problem is primarily with **overall ventilation** rather than a defect in gas exchange across the alveolar-capillary membrane.
*Right to left shunt*
- A right-to-left shunt would cause a **large A-a gradient**, as deoxygenated blood bypasses the lungs and mixes with oxygenated blood.
- While it causes **hypoxemia**, it would not typically be associated with hypercapnia unless very severe, and the A-a gradient calculation here does not support a significant shunt.
*Ventricular septal defect*
- A ventricular septal defect is a **structural heart abnormality** that can cause a left-to-right shunt initially, leading to pulmonary hypertension and eventually a right-to-left shunt (Eisenmenger syndrome).
- While it can cause hypoxemia due to shunting, it would not primarily manifest with increased pCO2 or the specific lung physical exam findings of decreased breath sounds and hyperresonance in the absence of other cardiac signs.
*Impaired gas diffusion*
- Impaired gas diffusion would lead to a **large A-a gradient** and **hypoxemia**, but typically not significant hypercapnia unless the impairment is extremely severe.
- Conditions like **pulmonary fibrosis** or **emphysema** cause impaired diffusion, but the patient's presentation and particularly the low A-a gradient do not support this.
*Ventilation/perfusion mismatch*
- A V/Q mismatch also causes a **large A-a gradient** and **hypoxemia**, as some areas of the lung are either poorly ventilated or poorly perfused.
- While it can cause hypercapnia in severe cases, the primary issue indicated by the low A-a gradient here is one of overall inadequate ventilation, not selective areas of ventilation-perfusion imbalance.
Question 9: A 68-year-old man with both severe COPD (emphysema) and newly diagnosed idiopathic pulmonary fibrosis presents with worsening dyspnea. His pressure-volume curve shows a complex pattern with features of both diseases. Static compliance measured at mid-lung volumes is 120 mL/cm H2O. His pulmonologist must decide on optimal management. Synthesizing the pathophysiology of both conditions, what represents the most significant clinical challenge in managing his combined disease?
A. Pulmonary rehabilitation cannot address the opposing mechanical derangements
B. The increased compliance from emphysema completely negates decreased compliance from fibrosis
C. The opposing effects on compliance create a pseudonormal total respiratory compliance masking disease severity (Correct Answer)
D. Emphysema treatment with bronchodilators will worsen fibrosis progression
E. Oxygen therapy beneficial for COPD will accelerate fibrotic changes
Explanation: ***The opposing effects on compliance create a pseudonormal total respiratory compliance masking disease severity***
- In **Combined Pulmonary Fibrosis and Emphysema (CPFE)**, the **increased lung compliance** from upper-lobe emphysema is offset by the **decreased compliance** from lower-lobe fibrosis.
- This results in a **pseudonormalization** of lung volumes (like FVC and TLC) and compliance measurements, which can lead to a significant **underestimation of disease severity** during clinical assessment.
*Pulmonary rehabilitation cannot address the opposing mechanical derangements*
- While mechanical derangements are complex, **pulmonary rehabilitation** remains a cornerstone of management to improve functional capacity and reduce dyspnea in both conditions.
- The challenge is not that rehabilitation is ineffective, but rather the **physiological monitoring** and objective assessment of progress are hampered by masked lung volumes.
*The increased compliance from emphysema completely negates decreased compliance from fibrosis*
- The two forces do not perfectly negate each other; rather, they coexist to produce a **paradoxical physiological profile** where static measurements appear mid-range while gas exchange is severely impaired.
- Patients often exhibit a **disproportionate reduction in DLCO** (diffusion capacity) despite relatively preserved lung volumes, indicating the negation is only superficial and numerical.
*Emphysema treatment with bronchodilators will worsen fibrosis progression*
- There is no clinical evidence suggesting that **bronchodilators** (beta-agonists or anticholinergics) used for COPD/emphysema accelerate the **pathological scarring** seen in idiopathic pulmonary fibrosis.
- Bronchodilators primarily target **airway smooth muscle** and do not interfere with the fibroblastic pathways driving interstitial lung disease.
*Oxygen therapy beneficial for COPD will accelerate fibrotic changes*
- **Long-term oxygen therapy (LTOT)** is used to treat chronic hypoxemia in both COPD and fibrosis and does not cause or accelerate **lung remodeling** or fibrosis.
- While high concentrations of inspired oxygen (FiO2) can cause **oxidative stress**, the flow rates used for clinical management do not contribute to the progression of pulmonary fibrosis.
Question 10: A 42-year-old woman with systemic sclerosis develops both pulmonary fibrosis and chest wall restriction from skin thickening. Her measured total respiratory system compliance is 30 mL/cm H2O. Testing with complete paralysis and positive pressure ventilation shows isolated lung compliance of 50 mL/cm H2O. She is being considered for immunosuppressive therapy versus supportive care. Evaluate which intervention would provide the greatest improvement in her respiratory mechanics.
A. Supportive care only, as both components contribute equally and irreversibly
B. Combined therapy targeting lung disease with chest wall mobilization (Correct Answer)
C. Aggressive immunosuppression targeting both lung and skin disease
D. Lung-directed therapy only, as it contributes more to total compliance reduction
E. Chest wall-directed physical therapy, as it is the primary limiting factor
Explanation: ***Combined therapy targeting lung disease with chest wall mobilization*** - The total respiratory compliance (Ct) is calculated using the formula **1/Ct = 1/Clung + 1/Cchest wall**; here, 1/30 = 1/50 + 1/Ccw, which calculates the **chest wall compliance** as 75 mL/cm H2O. - Both the lungs (50 mL/cm H2O) and chest wall (75 mL/cm H2O) are significantly below the **normal value of ~200 mL/cm H2O**, meaning both require intervention for meaningful improvement. *Supportive care only, as both components contribute equally and irreversibly* - While both contribute, they are not strictly equal (50 vs 75), and **systemic sclerosis**-associated lung/skin disease may respond to modern therapeutic interventions. - Labeling these as **irreversible** ignores potential benefits from immunosuppression in the active inflammatory stages of **interstitial lung disease**. *Aggressive immunosuppression targeting both lung and skin disease* - While immunosuppression addresses the underlying **pathophysiology**, it may not provide immediate mechanical relief for fixed **chest wall restriction**. - Effective management often requires adding **physical therapy** and mobilization to address the extrinsic mechanical constraint caused by **scleroderma skin thickening**. *Lung-directed therapy only, as it contributes more to total compliance reduction* - Although lung compliance (50) is lower than chest wall compliance (75), ignoring the **chest wall component** neglects a significant portion of the patient's **work of breathing**. - Solely treating the lung disease will not bypass the **extrinsic restriction** imposed by the tight skin and musculoskeletal changes. *Chest wall-directed physical therapy, as it is the primary limiting factor* - The calculations show that **lung compliance** is actually more severely reduced (50) than chest wall compliance (75). - Focusing only on the **chest wall** would leave the primary cause of the **restrictive ventilatory defect** (pulmonary fibrosis) unaddressed.
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
